IPAMORELIN 5 mg + CJC-1295 no DAC 5 mg

🧪 Ipamorelin 5 mg + CJC-1295 no DAC 5 mg – Combined research peptide for GH release & recovery This combined research peptide contains Ipamorelin (5 mg) and CJC-1295 no DAC (5 mg) together in one vial. This combination is very popular within research on growth hormone release, recovery processes and body composition. In research models, this stack is being studied for its synergistic effects: Ipamorelin selectively stimulates growth hormone release, while CJC-1295 no DAC supports natural GH pulses without long-term receptor binding. This results in a short-acting and well-controlled profile, which is ideal for precise research designs.

🔬 Product information at a glance

• Name: Ipamorelin + CJC-1295 no DAC
• Contents: 1 vial
• Dosage per vial:
  • Ipamorelin: 5 mg
  • CJC-1295 no DAC: 5 mg
• Form: Lyophilized (freeze-dried) powder
• Purity: ≥ 99% (HPLC tested)
• Peptide type: GH secretagogue (research classification)
• DAC: No (short-acting profile)

⚗️ What is this combination being investigated for? Within research environments, this combined peptide is widely studied in relation to:

• Growth hormone release and GH pulses
• Recovery and regeneration
• Fat metabolism and body composition
• Muscle preservation within metabolic research

🔁 Why Ipamorelin + CJC-1295 no DAC in one vial? In research, this combination in one vial offers clear advantages:

• Perfect synergy between the two substances
• Easy handling within research setups
• Short-acting effect without long-term hormonal stress
• Consistent ratio of Ipamorelin to CJC-1295

📦 Packaging & storage

• Contents: 1 vial of Ipamorelin 5 mg + CJC-1295 no DAC 5 mg
• Storage: Store cool and dry (2-8 °C), protected from light

🌍 Why choose this combined peptide?

• Very popular stack within GH-related research
• Combined in one vial for ease of use
• High purity and reliable laboratory quality
• Suitable for research on recovery, fat burning and body recomposition

⚠️ Important For research purposes only. Not suitable for human or animal use.

🎯 Combined stack or standalone Ipamorelin? This vial combines Ipamorelin (5mg) with CJC-1295 no DAC (5mg) for researchers studying their synergistic effect on GH pulses. Researchers who only need Ipamorelin on its own can compare this vial with Ipamorelin 5mg standalone. ❓ Frequently asked questions How should this combined vial be reconstituted? Reconstitute the lyophilized powder with bacteriostatic or sterile water. Add the water slowly along the vial wall and swirl gently to dissolve; do not shake. How is the purity of this combination verified? Every batch is HPLC-tested to confirm a purity of ≥99% for both peptides. How should the vial be stored? Store the vial in a cool, dry place between 2-8 °C, protected from light, and use reconstituted solution promptly. What comes included with this product? Each order includes 1 vial containing Ipamorelin 5 mg and CJC-1295 no DAC 5 mg combined. Why choose CJC-1295 no DAC instead of the DAC version? The no-DAC version has a shorter half-life, producing a research profile that mimics natural GH pulses rather than sustained elevation, which is preferred for studies requiring a more controlled release pattern.

Ipamorelin + CJC-1295 Combo — Reconstitution & Dosage Guide

This combo vial contains 5 mg Ipamorelin + 5 mg CJC-1295 (no DAC) in one vial. Reconstitute with the supplied 3 mL bacteriostatic water — both peptides reach a concentration of 1.67 mg/mL, so every draw delivers an equal amount of each. The standard per-dose stack is 6 units (100 mcg Ipamorelin + 100 mcg CJC-1295), 2–3x daily, injected subcutaneously on an empty stomach. For full dosing tables, cycling protocols and safety information, see our complete Ipamorelin Dosage Guide and CJC-1295 Dosage Guide.